Sun Pharmaceutical Industries has said that the US heath regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis. Sun Pharma...
EquityPanditβs Outlook for Sun PharmaΒ for the week Β (AprilΒ 03, 2017 βΒ AprilΒ 07, 2017) : SUN PHARMA: SUN PHARMA closed the week on negative note losing...